Unknown NA INTERVENTIONAL 2-arm NCT00842205

Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection

Role of Heme Oxygenase in the Pathogenesis od Hepatocellular Injury in Chronic HCV Infection

Sponsor: Charles University, Czech Republic

Conditions Chronic HCV Infection Nonalcoholic Steatohepatitis

Interventions Ribavarin pegylated interferon

Updated 5 times since 2017 Last updated: Feb 11, 2009 Started: Jan 31, 2007 Primary completion: Jun 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Chronic HCV Infection and Nonalcoholic Steatohepatitis and is currently ongoing. Charles University, Czech Republic leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles University, Czech Republic
IGA MZ, Czech Republic

Data source: Charles University, Czech Republic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia